News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Italy's PM Giorgia Meloni told Donald Trump to tend to his own popularity after he accused her of begging for a G7 photograph.
  • Trade idea: buy Nvidia targeting $240 within 45 trading days, with a protective stop at $195.
  • Ukrainian President Zelenskiy returned Poland's Order of the White Eagle after Warsaw revoked it over Kyiv renaming a unit tied to WWII-era fighters.
  • At least 30 people have died since May in Kigonze displacement camp, with some tests positive for Ebola and poor WASH raising contagion fears.
  • A Datafolha poll shows President Lula leading Flavio Bolsonaro and holding a first-round advantage ahead of October's presidential vote.
  • Wolfe Research finds Trump's approval has fallen and projects Democrats likely to flip the House.

Latest Articles

Ascent Solar Director Forrest Reynolds Offloads $47,250 in Common Stock

Ascent Solar Director Forrest Reynolds Offloads $47,250 in Common Stock

Forrest T. Reynolds, a director at Ascent Solar Technologies, Inc. (NASDAQ:ASTI), has sold 5,000 shares of the company's common stock, a transaction valued at $47,250. The sale occurred on June 2, 2026, with each share priced at $9.45. Following this transaction, Reynolds retains direct ownership of 31,334 shares. The timing of the sale coincides w…

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions

Eledon Pharmaceuticals announced that updated results from an investigator-initiated trial of tegoprubart, their lead anti-CD40L antibody, will be presented at the 2026 American Diabetes Association Scientific Sessions. The trial focuses on islet transplantation in type 1 diabetes patients, exploring immune-modulatory therapies to improve graft sur…

Xos Makes Its GFX Debut with Electric Vehicles, Powertrain Technology, and Mobile Charging for Public Fleets

Xos Makes Its GFX Debut with Electric Vehicles, Powertrain Technology, and Mobile Charging for Public Fleets

Xos, Inc. unveiled its comprehensive battery-electric vehicle range and mobile energy storage solutions at the Government Fleet Expo and Conference (GFX) 2026. Targeting public fleet managers facing tight budgets and procurement cycles under zero-emission mandates, Xos showcased its Charger Hub for scalable charging infrastructure without costly gr…

Satellogic to Participate in June Investor Conferences

Satellogic to Participate in June Investor Conferences

Satellogic, Inc. (NASDAQ: SATL), a company specializing in persistent global intelligence through satellite technology, will participate in two upcoming investor conferences in June 2026: the 16th Annual ROTH London Conference (in-person) and the Northland Growth Conference (virtual). Company executives will meet with investors to discuss business …

PayPal Executive Offloads Shares Amid Broader Market Context

PayPal Executive Offloads Shares Amid Broader Market Context

Suzan Kereere, President of Global Markets at PayPal Holdings, Inc., executed a stock sale on June 3, 2026, under a pre-established trading plan. This transaction occurs as the company navigates a period of stock price depreciation and reports fiscal results that align with market expectations. Concurrently, PayPal is broadening its operational rea…

Everpure Insider Transaction Analysis

Everpure Insider Transaction Analysis

John Colgrove, Chief Visionary Officer of Everpure, executed a significant share transaction through a Rule 10b5-1 plan, selling 10,280 shares at an average price of $85.32, totaling approximately $877,089. The transaction, conducted via The Colgrove Family Charitable Remainder Trust, involved a gift of the sold shares to the trust, which now holds…